glp-1 receptor agonists and next-generation metabolic hormone therapies in chronic kidney disease GLP-1 Receptor Agonists and Research
Description
Although these tests require a large number of studies for reliable inference, formal statistical tests for the assessment of publication bias were not performed, as the results would be unreliable and potentially misleading
The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders
19 Given the possibility that existing GLP-1 drugs are insufficient for treating Alzheimers and Parkinsons disease, some researchers are studying new versions of GLP-1s designed to solve that exact problem
Some studies suggest a beneficial effect, while others report exacerbations [65] (see Table 3)
doi:10.1016/j.eclinm.2024.102624 Palermo A, DOnofrio L, Eastell R, Schwartz AV, Pozzilli P, Napoli N
